A Data-Driven Method for Monitoring Quality of Medicines Using Statistical Techniques

What is it about?

This paper is about using statistical process control techniques to detect deviations in pharmaceutical products. Products that are manufactured in non-GMP conditions could be regarded as adulterated. Key points: It proposes a method for identifying adulterated or substandard medicines by analyzing their manufacturing quality data using statistical process control (SPC) tools. The idea is to establish baseline quality control data for authentic, high-quality medicines, then use SPC charts to identify when new batches fall outside the normal quality parameters, indicating potential adulteration or contamination. The author, Mostafa Essam Eissa, tested this approach using data from a pharmaceutical company in Asian countries. The SPC analysis was able to effectively detect batches that deviated from the normal quality profile. This provides a relatively simple and cost-effective way for pharmaceutical manufacturers and regulators to monitor product quality and quickly identify potential issues with counterfeit or substandard medicines. The goal is to help ensure the quality and safety of the drug supply, especially in developing countries where the problem of adulterated medicines is more prevalent. In summary, it describes a statistical quality control method for detecting adulterated or substandard pharmaceutical products.

Featured Image

Photo by Isaac Quesada on Unsplash

Photo by Isaac Quesada on Unsplash

Why is it important?

GMP stands for Good Manufacturing Practices, which are the quality control standards and guidelines that pharmaceutical manufacturers must follow to ensure the quality, safety, and efficacy of their products. If a pharmaceutical product is manufactured in conditions that do not meet GMP requirements, it could be considered adulterated. Adulteration refers to the introduction of impurities or substitution of an ingredient in a product, resulting in the product being of lower quality or potency than it should be. Products manufactured in non-GMP conditions are at higher risk of being contaminated, having incorrect formulation, or lacking the necessary quality controls. This can make them substandard or even unsafe for human consumption. Therefore, regulatory authorities typically regard such non-GMP manufactured products as adulterated and unfit for distribution and use. Hence, Adulterated Pharmaceutical Product Detection Using Statistical Process Control is an important article for several reasons: Protecting public health: Adulterated pharmaceutical products can pose a serious risk to public health. By using statistical process control (SPC), pharmaceutical manufacturers can detect and prevent the production of adulterated products.   Ensuring product quality: SPC is a quality control tool that can be used to monitor the manufacturing process and identify any deviations from quality standards. This can help to ensure that pharmaceutical products are of high quality and meet the needs of patients.   Reducing costs: Adulterated pharmaceutical products can be expensive to recall and can damage a company's reputation. By using SPC, pharmaceutical manufacturers can reduce the risk of producing adulterated products and save money. Improving regulatory compliance: Pharmaceutical manufacturers are required to comply with strict regulations regarding the quality of their products. SPC can help manufacturers to demonstrate compliance with these regulations.   Overall, this article provides valuable information that can be used to improve the quality and safety of pharmaceutical products.

Perspectives